PARTICIPANT PROFILE · SEC DISCLOSURES
Sullivan & Worcester Tel Aviv (Har-Even & Co.).
Law Firm · 1 transaction · 1 issuers in the database
Transaction history
Roles below apply to each specific transaction. Participation is supported by the linked transaction sources.
| Compare | Date | Company | Deal | Gross proceeds | Role on this deal |
|---|---|---|---|---|---|
| Sep 18, 2026SEC disclosed | Nasus Pharma LtdNSRX | ATM · Facility1 note | No cash proceeds | Issuer Counsel |
SEC deal terms · FMP market data where available · Initial research sample, not complete market coverage. AI-assisted source review; original evidence is available in each report. Names and tickers reflect the transaction date. A dash (—) means the value is unavailable.